Riz Hatton

Jun 6, 2024 | beckersasc.com | Riz Hatton

Here are three updates on ASC activity in the South that Becker's has reported on since May 9: 1. The Biloxi (Miss.) City Council recently approved a $5 million tax increment financing plan for a medical center that will include an ASC. 2. A new ASC is under construction at a shopping center in Cookeville, Tenn. 3. Panoramic Health opened a Brandon, Fla.-based ASC in partnership with Tampa, Fla.-based Florida Kidney Physicians, the state's largest nephrology group.

Jun 5, 2024 | beckersasc.com | Riz Hatton

Virginia is the state where people have the highest income, according to personal finance site WalletHub. In a report released June 4, WalletHub determined the states where people have the best incomes. The site compared the 50 states and Washington, D.C., based on three metrics measuring income for different segments of the population, adjusted for the cost of living index: average annual income of the top 5%, median annual household income and average annual income of the bottom 20%.

May 31, 2024 | beckersasc.com | Riz Hatton

Being a cardiologist comes with many challenges. This information comes from Medscape's "Cardiologist Compensation Report 2024" which was released on May 24.

May 30, 2024 | beckersasc.com | Riz Hatton

Here are seven medical office building deals that total more than $121 million that Becker's has reported on since May 1: 1. Sila Realty Trust acquired a medical outpatient building in Reading, Pa., for $10.5 million. 2. A Jacksonville, Fla.-based medical office building sold for $12.05 million. 3. A 10-story medical office building in Boston has been acquired for $36.4 million. 4. Anchor Health Properties acquired a 70,418-square-foot medical office building in Sarasota, Fla., for $31.8 million.

May 29, 2024 | beckershospitalreview.com | Riz Hatton

- The FDA has approved Bkemv as the first interchangeable biosimilar to Soliris to treat certain rare diseases. Bkemv is approved for the treatment of patients with paroxysmal nocturnal hemoglobinuria and for those with atypical hemolytic uremic syndrome, according to a May 28 news release from the FDA. Bkemv is the 53rd approved biosimilar in the U.S.